Amphotericin B
Who holds supplier records for Amphotericin B? 4 organisations hold a current record for Amphotericin B: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), India (1) and Denmark (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Amphotericin B: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/amphotericin-b
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Amphotericin B. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ASENCE PHARMA PRIVATE LTDIndiaCEPActive DMF 13819, 26184, 26375 · latest filing Sept 2012
- NORTH CHINA PHARMACEUTICAL HUASHENG CO LTDChinaCEP Company GMP cert on recordActive DMF 18157 · latest filing Mar 2005
- Xellia PharmaceuticalsDenmarkCEP Company GMP cert on recordActive DMF 13682 · latest filing Sept 1998
- Zhejiang Tiantai Pharmaceutical Co., Ltd.ChinaCEPActive DMF 43575 · latest filing Feb 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Amphotericin B, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ASENCE PHARMA PRIVATE LIMITED Vadodara | IN | CEP 2026-186 - Rev 00 Amphotericin B | Jun 2026 | — |
| ZHEJIANG TIANTAI PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2023-152 - Rev 01 Amphotericin B, Process II, for use in the manufacture of parenteral preparations | Oct 2025 | — |
| North China Pharmaceutical Huasheng Co., Ltd. Shijiazhuang | CN | R1-CEP 2005-212 - Rev 04 Amphotericin B | Aug 2023 | — |
| XELLIA PHARMACEUTICALS APS Copenhagen S | DK | R1-CEP 2002-079 - Rev 09 Amphotericin B | May 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Amphotericin B are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- USA · Inactive DMF 13701 · filed Sept 1998
- United States · Inactive DMF 13544 · filed Sept 1998
- CELL PRODUCTS INCInactive DMF 13646, 13648 · filed Sept 1998
- SHANGHAI ASIA PIONEER CO LTDInactive DMF 13224 · filed Apr 1998
Overview
Amphotericin B is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL267345).
Chemical identity
- IUPAC name
- (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid
- Canonical SMILES
- C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O
- InChIKey
- APKFDSVGJQXUKY-INPOYWNPSA-N
- Synonyms
- Abelcet, Abelcet, liposomal amphotericin b, Ambil, Ambisome, Amfotericina b, Amophotericin b, Ampho-moronal, Amphotec, Amphotercin b, Amphotericin, Amphotericin b, Amphotericin b deoxycholate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Lipid-based Polyene Antifungal; Polyene Antifungal
- Chemical structure
- Polyenes
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Amphotericin B?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Amphotericin B: ASENCE PHARMA PRIVATE LTD (India), NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD (China), Xellia Pharmaceuticals (Denmark) and Zhejiang Tiantai Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Amphotericin B Drug Master Files are active?
ASENCE PHARMA PRIVATE LTD (DMF 13819, 26184), NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD (DMF 18157), Xellia Pharmaceuticals (DMF 13682) and Zhejiang Tiantai Pharmaceutical Co., Ltd. (DMF 43575). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Amphotericin B records mean?
4 organisations have only inactive Type II DMFs for Amphotericin B. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Amphotericin B have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Amphotericin B on the EDQM register, including ASENCE PHARMA PRIVATE LIMITED Vadodara (IN), ZHEJIANG TIANTAI PHARMACEUTICAL CO., LTD. Taizhou City (CN), North China Pharmaceutical Huasheng Co., Ltd. Shijiazhuang (CN) and XELLIA PHARMACEUTICALS APS Copenhagen S (DK). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Amphotericin B supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Amphotericin B?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.